MiR-302b as a Combinatorial Therapeutic Approach to Improve Cisplatin Chemotherapy Efficacy in Human Triple-Negative Breast Cancer

Introduction: Chemotherapy is still the standard of care for triple-negative breast cancers (TNBCs). Here, we investigated miR-302b as a therapeutic tool to enhance cisplatin sensitivity in vivo and unraveled the molecular mechanism. Materials and Methods: TNBC-xenografted mice were treated with miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Cataldo, Alessandra, Romero-Cordoba, Sandra, Plantamura, Ilaria, Cosentino, Giulia, Hidalgo-Miranda, Alfredo, Tagliabue, Elda, Iorio, Marilena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464985/
https://www.ncbi.nlm.nih.gov/pubmed/32806777
http://dx.doi.org/10.3390/cancers12082261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464985/
https://www.ncbi.nlm.nih.gov/pubmed/32806777
http://dx.doi.org/10.3390/cancers12082261

Ejemplares similares